Dr. M. Karen Newell-rogers
Sfeir Georges Semaan
Dr. Newell-Rogers is our Chief Scientist and the primary inventor of both Targeted Peptide Technology (TPT) and Metabolic Disruption Technology (MDT). She is the Raleigh R. White, Jr. Endowed Professor of Surgical Research, Department of Surgery, College of Medicine, at Texas A&M Health Sciences Center and Scott and White Hospital in Temple, Texas. Dr. Newell-Rogers is also the Director of the newly formed Center for Cell Death and Differentiation at TAMHSC/Scott and White Hospital. Newell-Rogers was formerly at the University of Colorado, Colorado Springs, as Scientific Director of the CU Institute of Bioenergetics and Immunology and as the Clement and Margaret Markert Endowed Professor of Biology. She has authored or co-authored several dozen peer-reviewed papers predominantly focused on immunology and cellular metabolism, and she holds over 30 issued or pending patents.